# Treatment of Slow-flow After Primary Percutaneous Coronary Intervention With Flow-mediated Hyperemia

> **NCT04685941** · NA · COMPLETED · sponsor: **Fundación EPIC** · enrollment: 67 (actual)

## Conditions studied

- Coronary Microvascular Disease
- Myocardial Infarction

## Interventions

- **DRUG:** Drug-mediated hyperemia
- **OTHER:** Flow-mediated hyperemia

## Key facts

- **NCT ID:** NCT04685941
- **Lead sponsor:** Fundación EPIC
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-01-25
- **Primary completion:** 2022-10-31
- **Final completion:** 2022-10-31
- **Target enrollment:** 67 (ACTUAL)
- **Last updated:** 2022-11-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04685941

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04685941, "Treatment of Slow-flow After Primary Percutaneous Coronary Intervention With Flow-mediated Hyperemia". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04685941. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*